The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,735.50
Bid: 1,735.00
Ask: 1,736.00
Change: -4.50 (-0.26%)
Spread: 1.00 (0.058%)
Open: 1,730.00
High: 1,744.50
Low: 1,729.00
Prev. Close: 1,740.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

Thu, 07th Oct 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

CITIGROUP RAISES LEGAL & GENERAL PRICE TARGET TO 336 (301) PENCE - 'BUY'

----------

MORGAN STANLEY CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,555 PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS SCHRODERS TARGET TO 3,700 (3,890) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS HARGREAVES LANDSDOWN TARGET TO 1,381 PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS ABRDN PRICE TARGET TO 289 (305) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES PRUDENTIAL PRICE TARGET TO 1,764 (1,706) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RENTOKIL INITIAL TARGET TO 645 (620) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN PRICE TARGET TO 3,500 (3,320) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES ANGLO AMERICAN PRICE TARGET TO 4,100 (3,900) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ANGLO AMERICAN PRICE TARGET TO 3,700 (4,300) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS RIO TINTO PRICE TARGET TO 5,400 (6,910) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS RIO TINTO PRICE TARGET TO 5,400 (6,900) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES ANTOFAGASTA PRICE TARGET TO 1,750 (1,700) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES GLENCORE PRICE TARGET TO 470 (430) PENCE - 'BUY'

----------

BERENBERG CUTS BHP GROUP PRICE TARGET TO 2,200 (2,300) PENCE - 'HOLD'

----------

JEFFERIES CUTS POLYMETAL PRICE TARGET TO 1,725 (1,900) PENCE - 'BUY'

----------

BERENBERG CUTS POLYMETAL PRICE TARGET TO 2,200 (2,300) PENCE - 'BUY'

----------

JEFFERIES CUTS FRESNILLO PRICE TARGET TO 1,280 (1,300) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES RELX PRICE TARGET TO 2,500 (2,430) PENCE - 'OUTPERFORM'

----------

UBS RAISES RELX PRICE TARGET TO 2,135 (2,040) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES TESCO PRICE TARGET TO 330 (300) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES TESCO PRICE TARGET TO 320 (310) PENCE - 'BUY'

----------

BARCLAYS RAISES TESCO PRICE TARGET TO 325 (310) PENCE - 'OVERWEIGHT'

----------

BERNSTEIN RAISES TESCO PRICE TARGET TO 330 (280) PENCE - 'OUTPERFORM'

----------

RBC CUTS BURBERRY PRICE TARGET TO 1,950 (2,160) PENCE - 'SECTOR PERFORM'

----------

FTSE 250

----------

MORGAN STANLEY RAISES CENTRICA TO 'OVERWEIGHT' (EQUAL WEIGHT) - TARGET 75 (58) PENCE

----------

MORGAN STANLEY CUTS MAN GROUP PRICE TARGET TO 253 (255) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS ASHMORE GROUP TARGET TO 376 (412) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 340 (360) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS HOMESERVE TARGET TO 1,020 (1,110) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK INITIATES MARSHALLS WITH 'BUY' - TARGET 885 PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING TO 'BUY' ('HOLD') - TARGET 200 PENCE

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 137 (138) PENCE - 'BUY'

----------

JEFFERIES CUTS CENTAMIN PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

RBC RAISES PAGEGROUP PRICE TARGET TO 760 (700) PENCE - 'OUTPERFORM'

----------

RBC CUTS TRITAX BIG BOX PRICE TARGET TO 260 (265) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES BRITVIC PRICE TARGET TO 1050 (900) PENCE - 'BUY'

----------

JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 2,220 (2,168) PENCE - 'BUY'

----------

JEFFERIES RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,445 (2,415) PENCE - 'HOLD'

----------

DZ BANK CUTS FAIR VALUE FOR TUI TO 2.00 (2.60) EUR - 'SELL'

----------

MORGAN STANLEY CUTS TUI PRICE TARGET TO 140 (160) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES GEM DIAMONDS TO 'BUY' ('HOLD') - TARGET 80 (70) PENCE

----------

BERENBERG RAISES IMPAX GROUP PRICE TARGET TO 1,400 (1,360) PENCE - 'BUY'

----------

BERENBERG RAISES PENDRAGON PRICE TARGET TO 28 (27) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 3,100 (2,750) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES KENMARE RESOURCES PRICE TARGET TO 580 (530) PENCE - 'BUY'

----------

BERENBERG CUTS GRIFFIN PRICE TARGET TO 175 (200) PENCE - 'BUY'

----------

BERENBERG CUTS GREATLAND GOLD PRICE TARGET TO 26 (29) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 320 (300) PENCE - 'BUY'

----------

BERENBERG RAISES NICHOLS PRICE TARGET TO 1,350 (1,200) PENCE - 'HOLD'

----------

BERENBERG RAISES FEVERTREE DRINKS PRICE TARGET TO 2,700 (2,500) PENCE - 'BUY'

----------

BERENBERG RAISES AG BARR PRICE TARGET TO 570 (450) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES SUPERMARKET INCOME REIT PRICE TARGET TO 136 (134) PENCE - 'BUY'

----------

JPMORGAN RAISES PETROFAC PRICE TARGET TO 170 (120) PENCE - 'NEUTRAL'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.